Understanding Primary Infertility
Understanding Primary Infertility
Coital errors, such as incorrect timing or position during intercourse, directly impact the likelihood of conception by affecting sperm deposition . Psychological factors, particularly anxiety, can lead to hormonal imbalances that interfere with ovulation and the menstrual cycle, further complicating conception efforts . These aspects underscore the intricate link between physical and emotional well-being in fertility management.
When traditional infertility treatments fail, advanced reproductive technologies such as In Vitro Fertilization (IVF) with Embryo Transfer (ET) for female infertility, and Intracytoplasmic Sperm Injection (ICSI) for male infertility are recommended . These approaches directly handle gametes to facilitate fertilization and are critical interventions for severe cases where simpler therapeutic options are insufficient .
Primary causes of male infertility include incomplete development of testes, late descent or non-descent of testes, and damage to testes from conditions such as mumps orchitis, X-ray exposure, and trauma . Secondary causes involve trauma or surgeries like herniorrhaphy leading to obstructive azoospermia, and issues like impotence, premature ejaculation, and retrograde ejaculation affecting sperm deposition, sometimes influenced by medication such as tricyclic antidepressants .
For women with Polycystic Ovary Syndrome (PCOS), laparoscopic ovarian drilling is a surgical intervention that can enhance ovulation . This procedure involves making small perforations in the ovarian surface, which can reduce levels of androgens and help restore normal ovulation patterns . It is particularly useful for those who do not respond to medication alone.
Therapeutic options to improve sperm include medications like clomiphene, hCG, hMG, and GnRH which address hormonal deficiencies . Surgical options like TESA (Testicular Sperm Aspiration) and MESA (Microsurgical Epididymal Sperm Aspiration) are used for sperm retrieval when obstructive azoospermia is present . Corrective surgery for varicocele is also considered to enhance fertility outcomes .
Semen analysis is a critical tool in assessing male infertility, focusing on several parameters including semen volume (2-6 ml), liquefaction time (30 minutes), sperm count (>20 million/ml), sperm motility (>50% motile), and morphology (>30% normal). These metrics help identify underlying issues such as insufficient sperm production or motility problems, guiding subsequent infertility treatment plans .
Female infertility is assessed through clinical examination, evaluation of reproductive history, and diagnostic tests. Crucial components include physical examination of body habitus, breast, thyroid, and signs of conditions like acne and hirsutism . Ultrasonography scans for uterus and ovaries, follicular imaging, and measurement of endometrial thickness at ovulation time are performed as well . Hormonal assays measure key hormones such as FT4, TSH, PRL, FSH, and LH . Additionally, tests for tubal patency such as hysterosalpingography and sonosalpingography are conducted .
Unexplained infertility, accounting for approximately 10% of cases after two years of trying to conceive, presents significant challenges because typical causes have been ruled out or treated without success . This diagnosis often leads couples to pursue advanced reproductive technologies such as IVF or ICSI as potential solutions, despite the lack of a specific identifiable issue . It highlights the complexity of reproductive biology and the limitations of existing diagnostic methods.
Contraindications for hysterosalpingography include performing the test immediately prior to menses, after curettage, in the presence of recent acute salpingitis, or suspected TB/lower genital tract infections . Risks involve severe pain potentially leading to collapse, intravasation of dye, peritoneal infections, and generalized sensitivity reactions, thereby necessitating careful patient selection and management . These factors are significant as they directly impact patient safety and the validity of the test results.
Hormonal therapies for treating ovulation disorders in female infertility include Clomiphene citrate, gonadotrophins, and bromocriptine . Clomiphene citrate stimulates ovulation by working as a selective estrogen receptor modulator, thereby increasing gonadotropin release from the pituitary . Gonadotrophins directly supplement existing gonadotropin levels to stimulate ovarian follicles . Bromocriptine reduces high levels of prolactin, which can interfere with normal ovulation .